C. Truffot-Pernot

6.7k citations
96 papers · 5.1k indexed · 1 hit paper · h-index 34

Impact in

Papers in

    • Tuberculosis Research and Epidemiology 75
    • Mycobacterium research and diagnosis 63
    • Pneumocystis jirovecii pneumonia detection and treatment 9

C. Truffot-Pernot

93 papers receiving 4.9k citations

Hit Papers

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis 2004 · 1.6k citations
1.6k200420262011201850010001.5k

Peers

C. Truffot-Pernot
Comparison fields: 5 of 110
  • Infectious Diseases 3.9k
  • Molecular Medicine 632
  • Epidemiology 3.4k
  • Small Animals 284
  • Microbiology 26
Replace Michael H. Cynamon with:
Michael H. Cynamon United States
Sven Hoffner Sweden
Diane Ordway United States
Eric L. Nuermberger United States
Gyanu Lamichhane United States
Béate Heym France
Hugo L. David France
Shashikant Srivastava United States
Nicolas Véziris France
J Grosset France
C. Truffot-Pernot relative to Michael H. Cynamon United States Michael H. Cynamon's profile →
Citations per field
00.5×1.5×
Michael H. Cynamon · 1×
Citations per year

Countries citing papers authored by C. Truffot-Pernot

Since Specialization
Citations

This map shows the geographic impact of C. Truffot-Pernot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Truffot-Pernot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Truffot-Pernot more than expected).

Fields of papers citing papers by C. Truffot-Pernot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Truffot-Pernot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Truffot-Pernot. The network helps show where C. Truffot-Pernot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside C. Truffot-Pernot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Truffot-Pernot Line = papers co-authored together C. Truffot-Pernot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 200961
2 200851
3 200717
4 200621
5 20063
6
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Hit paper breakdown →
20041632
7 200431
8 20049
9 200413
10 2001108
11 200026
12 199825
13
Bactériologie de la tuberculose et des infections à mycobactéries non tuberculeuses.
19970
14 1995116
15 199432
16 199391
17 199152
18 198921
19
[Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
198810
20 198830

About C. Truffot-Pernot

C. Truffot-Pernot is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Small Animals and Surgery, having authored 96 papers that have together received 5.1k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (75 papers), Mycobacterium research and diagnosis (63 papers), Cancer therapeutics and mechanisms (23 papers), Infectious Diseases and Tuberculosis (14 papers), Phenothiazines and Benzothiazines Synthesis and Activities (11 papers), Antibiotic Resistance in Bacteria (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers) and Infectious Diseases and Mycology (8 papers). The work is most often cited by research in Infectious Diseases (3.9k citations), Molecular Medicine (632 citations), Epidemiology (3.4k citations), Small Animals (284 citations) and Microbiology (26 citations). C. Truffot-Pernot has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include J Grosset, Vincent Jarlier, Nacer Lounis, Emmanuelle Cambau, Nicolas Véziris, Koen Andries, Wladimir Sougakoff, Botao Ji, Hans Christian Winkler and Jef Van Gestel. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, American Journal of Respiratory and Critical Care Medicine, Journal of Clinical Microbiology, European Respiratory Journal and Clinical Microbiology and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026